Yang S N, Fior D R, Hedlund P B, Narváez J A, Agnati L F, Fuxe K
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Neurosci Lett. 1994 Apr 25;171(1-2):27-31. doi: 10.1016/0304-3940(94)90596-7.
The cardiovascular effects of adrenaline microinjected alone or together with neuropeptide Y (NPY) receptor agonists into the nucleus tractus solitarius (Sol) of the anaesthetized rat have been investigated in order to evaluate NPY/adrenergic receptor interactions. In the dose range 0.05-20 nmol, adrenaline microinjected unilaterally into the Sol produced significant dose-related reductions in mean arterial blood pressure and heart rate. The vasodepressor action of a close to ED50 dose of adrenaline (0.5 nmol) was significantly counteracted by a threshold dose of NPY (1-36) (1 pmol) and of the NPY Y1 receptor agonist [Leu31,Pro34]NPY (2.5 pmol) microinjected into the Sol, but not by a threshold dose of NPY(13-36)(50 fmol), a selective Y2 receptor agonist. The present study provides evidence for an antagonistic NPY Y1/adrenergic receptor interaction in the Sol of the rat, involved in cardiovascular regulation.
为了评估神经肽Y(NPY)/肾上腺素能受体的相互作用,研究人员将肾上腺素单独或与NPY受体激动剂一起微量注射到麻醉大鼠的孤束核(Sol)中,并观察其对心血管系统的影响。在0.05 - 20 nmol的剂量范围内,单侧微量注射到Sol中的肾上腺素可使平均动脉血压和心率显著降低,且呈剂量相关性。接近半数有效剂量(ED50)的肾上腺素(0.5 nmol)的降压作用,可被微量注射到Sol中的阈剂量NPY(1 - 36)(1 pmol)和NPY Y1受体激动剂[Leu31,Pro34]NPY(2.5 pmol)显著抵消,但不能被阈剂量的NPY(13 - 36)(50 fmol)(一种选择性Y2受体激动剂)抵消。本研究为大鼠Sol中存在参与心血管调节的拮抗性NPY Y1/肾上腺素能受体相互作用提供了证据。